切换至 "中华医学电子期刊资源库"

中华乳腺病杂志(电子版) ›› 2013, Vol. 07 ›› Issue (03) : 206 -209. doi: 10.3877/cma. j. issn.1674-0807.2013.03.012

综述

乳腺癌前哨淋巴结微转移的研究进展
刘丹丹1, 张建国1,()   
  1. 1.150086 黑龙江,哈尔滨医科大学附属第二临床医院乳腺外科
  • 收稿日期:2012-09-29 出版日期:2013-06-01
  • 通信作者: 张建国

Research progress on sentinel lymph node micrometastasis in breast cancer

Dan-dan LIU, Jian-guo ZHANG()   

  • Received:2012-09-29 Published:2013-06-01
  • Corresponding author: Jian-guo ZHANG
引用本文:

刘丹丹, 张建国. 乳腺癌前哨淋巴结微转移的研究进展[J/OL]. 中华乳腺病杂志(电子版), 2013, 07(03): 206-209.

Dan-dan LIU, Jian-guo ZHANG. Research progress on sentinel lymph node micrometastasis in breast cancer[J/OL]. Chinese Journal of Breast Disease(Electronic Edition), 2013, 07(03): 206-209.

[1]
Lyman GH, Giuliano AE, Somerfield MR, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer[J]. J Clin Oncol,2005,23(30): 7703-7720.
[2]
Bilimoria KY, Bentrem DJ, Hansen NM, et al. Comparison of sentinel lymph node biopsy alone and completion axillary node dissection for node-positive breast cancer[J]. J Clin Oncol,2009,27(18): 2946-2953.
[3]
Edge SB, Byrd DR, Compton CC, et al. AJCC cancer staging manual[M]. 7th ed. New York: Springer,2010.
[4]
席晨辉,庄大勇,郑鲁明,等.术中冰冻切片联合快速免疫组织化学染色检测乳腺癌前哨淋巴结微转移的临床研究[J/CD]. 中华乳腺病杂志: 电子版,2011,5(4): 408-418.
[5]
Le Frére-Belda MA, Bats AS, Gillaizeau F, et al. Diagnostic performance of one-step nucleic acid amplification for intraoperative sentinel node metastasis detection in breast cancer patients [J].Int J Cancer,2012,130(10): 2377-2386.
[6]
Iinuma H, Tamura J, Omoto D, et al. Accurate and rapid novel genetic diagnosis for detection of sentinel lymph node metastasis in breast cancer patients[J]. Br J Cancer,2012,107(4): 724-731.
[7]
Van Deurzen CH, van Hillegersberg R, Hobbelink MG, et al.Predictive value of tumor load in breast cancer sentinel lymph nodes for second echelon lymph node metastases [J]. Cell Oncol,2007,29(6): 497-505.
[8]
Noguchi M. Avoidance of axillary lymph node dissection in selected patients with node-positive breast cancer[J]. Eur J Surg Oncol,2008,34(2): 129-134.
[9]
Kumar S, Bramlage M, Jacks LM, et al. Minimal disease in the sentinel lymph node: how to best measure sentinel node micrometastases to predict risk of additional non-sentinel lymph node disease[J].Ann Surg Oncol,2010,17(11): 2909-2919.
[10]
Ozcinar B, Muslumanoglu M, Igci A, et al. Clinical importance of micrometastasis in sentinel lymph nodes [J].Breast,2011,20(1): 31-33.
[11]
Cox CE, Kiluk JV, Riker AI, et al. Significance of sentinel lymph node micrometastases in human breast cancer[J]. J Am Coll Surg,2008,206(2): 261-268.
[12]
Viale G, Maiorano E, Mazzarol G, et al. Histologic detection and clinical implications of micrometastases in axillary sentinel lymph nodes for patients with breast carcinoma[J]. Cancer,2001,92(6): 1378-1384.
[13]
Gipponi M, Canavese G, Lionetto R, et al. The role of axillary lymph node dissection in breast cancer patients with sentinel lymph node micrometastases[J]. Eur J Surg Oncol,2006,32(2): 143-147.
[14]
Di Tommaso L, Arizzi C, Rahal D, et al. Anatomic location of breast cancer micrometastasis in sentinel lymph node predicts axillary status[J]. Ann Surg,2006,243(5): 706-707.
[15]
Joyce DP,Solon JG,Prichard RS,et al. Is there a requirement for axillary lymph node dissection following identification of micro-metastasis or isolated tumour cells at sentinel node biopsy for breast cancer? [J].Surgeon,2012,10(6): 326-329.
[16]
Yi M, Giordano SH, Meric-Bernstam F, et al. Trends in and outcomes from sentinel lymph node biopsy (SLNB) alone vs.SLNB with axillary lymph node dissection for node-positive breast cancer patients: experience from the SEER database[J]. Ann Surg Oncol,2010,17(suppl 3): 343-351.
[17]
Montagna E, Viale G, Rotmensz N, et al. Minimal axillary lymph node involvement in breast cancer has different prognostic implications according to the staging procedure[J].Breast Cancer Res Treat,2009,118(2): 385-394.
[18]
Yegiyants S, Romero LM, Haigh PI, et al. Completion axillary lymph node dissection not required for regional control in patients with breast cancer who have micrometastases in a sentinel node[J]. Arch Surg,2010,145(6): 564-569.
[19]
Viehl CT, Langer I, Guller U, et al. Prognostic impact and therapeutic implications of sentinel lymph node micrometastases in early-stage breast cancer patients[J]. J Surg Oncol,2011,103(6): 531-533.
[20]
Galimberti V, Botteri E, Chifu C, et al. Can we avoid axillary dissection in the micrometastatic sentinel node in breast cancer?[J]. Breast Cancer Res Treat,2011,131(3): 819-825.
[21]
De Boer M, van Deurzen CH, van Dijck JA, et al.Micrometastases or isolated tumor cells and the outcome of breast cancer[J]. N Engl J Med,2009,361(7): 653-663.
[22]
Van Diest PJ, de Boer M, van Deurzen CH, et al.Micrometastases and isolated tumor cells in breast cancer are indeed associated with poorer outcome[J]. J Clin Oncol,2010,28(9): e140.
[23]
Gobardhan PD, Elias SG, Madsen EV, et al. Prognostic value of micrometastases in sentinel lymph nodes of patients with breast carcinoma: a cohort study[J]. Ann Oncol,2009,20(1): 41-48.
[24]
Reed J,Rosman M,Verbanac KM,et al. Prognostic implications of isolated tumor cells and micrometastases in sentinel nodes of patients with invasive breast cancer: 10-year analysis of patients enrolled in the prospective East Carolina University/Anne Arundel Medical Center Sentinel Node Multicenter Study[J]. J Am Coll Surg,2009,208(3): 333-340.
[25]
Tjan-Heijnen VC, Pepels MJ, de Boer M. Prognostic impact of isolated tumor cells and micrometastases in axillary lymph nodes of breast cancer patients[J]. Breast Dis,2010,31(2): 107-113.
[1] 李洋, 蔡金玉, 党晓智, 常婉英, 巨艳, 高毅, 宋宏萍. 基于深度学习的乳腺超声应变弹性图像生成模型的应用研究[J/OL]. 中华医学超声杂志(电子版), 2024, 21(06): 563-570.
[2] 周荷妹, 金杰, 叶建东, 夏之一, 王进进, 丁宁. 罕见成人肋骨郎格汉斯细胞组织细胞增生症被误诊为乳腺癌术后骨转移一例[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 380-383.
[3] 河北省抗癌协会乳腺癌专业委员会护理协作组. 乳腺癌中心静脉通路护理管理专家共识[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 321-329.
[4] 刘晨鹭, 刘洁, 张帆, 严彩英, 陈倩, 陈双庆. 增强MRI 影像组学特征生境分析在预测乳腺癌HER-2 表达状态中的应用[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 339-345.
[5] 张晓宇, 殷雨来, 张银旭. 阿帕替尼联合新辅助化疗对三阴性乳腺癌的疗效及预后分析[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 346-352.
[6] 邱琳, 刘锦辉, 组木热提·吐尔洪, 马悦心, 冷晓玲. 超声影像组学对致密型乳腺背景中非肿块型乳腺癌的诊断价值[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 353-360.
[7] 程燕妮, 樊菁, 肖瑶, 舒瑞, 明昊, 党晓智, 宋宏萍. 乳腺组织定位标记夹的应用与进展[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 361-365.
[8] 涂盛楠, 胡芬, 张娟, 蔡海峰, 杨俊泉. 天然植物提取物在乳腺癌治疗中的应用[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 366-370.
[9] 朱文婷, 顾鹏, 孙星. 非酒精性脂肪性肝病对乳腺癌发生发展及治疗的影响[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 371-375.
[10] 葛睿, 陈飞, 李杰, 李娟娟, 陈涵. 多基因检测在早期乳腺癌辅助治疗中的应用价值[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(05): 257-263.
[11] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[12] 韩萌萌, 冯雪园, 马宁. 乳腺癌改良根治术后桡神经损伤1例[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 117-118.
[13] 张志兆, 王睿, 郜苹苹, 王成方, 王成, 齐晓伟. DNMT3B与乳腺癌预后的关系及其生物学机制[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 624-629.
[14] 王玲艳, 高春晖, 冯雪园, 崔鑫淼, 刘欢, 赵文明, 张金库. 循环肿瘤细胞在乳腺癌新辅助及术后辅助治疗中的应用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 630-633.
[15] 赵林娟, 吕婕, 王文胜, 马德茂, 侯涛. 超声引导下染色剂标记切缘的梭柱型和圆柱型保乳区段切除术的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 634-637.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?